{"id":590210,"date":[{"year":1980,"month":1,"day":31}],"page":"4","source":"","region":"","masthead":"","special_issue":"向科学进军","column":"科技新花","genre":"","count":"219","ytitle":"","mtitle":"治疗射线损伤的新针剂","ftitle":"","authors":["张岩松"],"text":[{"type":"paragraph","text":"大家知道，各种放射性射线，对人体均有杀伤作用。现在，上海生物制品研究所研制成功了一种新针剂——甲2巨球蛋白，对放射性损伤等疗效较好。"},{"type":"paragraph","text":"这种针剂是从健康人的血浆和胎盘血中，经低温乙醇及硫酸铵盐析法提制而得的一种新的血液制剂。内含一定数量的甲2巨球蛋白，可促进被辐射肌体损伤后的造血组织功能的恢复。能用于治疗放射所致的皮肤和粘膜局部损伤、放射治疗后手术创口崩裂、溃疡及放疗后引起的直肠出血反应，等等。"},{"type":"paragraph","text":"(张岩松)"}]}